SUPX:NASDAQSuperX AI Technology Limited Analysis
Data as of 2026-08-23 - not real-time
$8.52
Latest Price
9/10Risk
Risk Level: High
Executive Summary
SuperX AI Technology Limited is priced at $8.52 and its moving averages line up in bearish order, the shorter trailing the longer. Over a rolling month the price has gained 8.4%. With RSI at 65.2 the momentum picture is approaching overbought, alongside a bullish MACD signal. Watch $5.61 as support and $8.58 as the nearer resistance level.
Revenue is growing at 283.8%.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 109.9%, a beta of 1.89 and a maximum drawdown of 92.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
Revenue is growing at 283.8%.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 109.9%, a beta of 1.89 and a maximum drawdown of 92.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
Top Market Events
media 1145886 SINGAPORE, July 22, 2026 /PRNewswire/ -- SuperX AI Technology Limited NASDAQ: SUPX, hereinafter referred...SINGAPORE, July 21, 2026 /PRNewswire/ -- SuperX AI Technology Limited NASDAQ: SUPX, hereinafter referred to as "SuperX"...SINGAPORE, Aug. 7, 2026 /PRNewswire/ -- SuperX AI Technology Limited Nasdaq: SUPX, the 'Company' or 'SuperX' , a...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 13.66
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 13.66
- 30-day volatility of 109.9%
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Negative return on equity of -85.6%
- Revenue growth of +283.8%
- Negative free cash flow
Key Metrics & Analysis
Financial Health
Revenue Growth283.80%
ROE-85.63%
ROA-27.27%
Debt/Equity1.35
P/B Ratio1.8
Op. Cash Flow$-42260352
Free Cash Flow$-15346198
Industry P/E35.2
Technical Analysis
TrendBearish
RSI65.2
Support$5.61
Resistance$8.58
MA 20$6.82
MA 50$7.42
MA 200$13.66
MACDBullish
VolumeStable
Fear & Greed Index94.41
Valuation
GradeFair
TypeGrowth
Risk Assessment
Beta1.89
Volatility109.85%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.